17 September 2021

The Royal Melbourne Hospital (RMH) researchers have received $17,480,419 in funding from the latest round of the National Health and Medical Research Council’s (NHMRC) grant announcements this week.

MRI scan
17 September 2021

The Royal Melbourne Hospital (RMH) researchers have received $17480,419 in funding from the latest round of the National Health and Medical Research Council’s (NHMRC) grant announcements this week.

Melbourne Brain Centre at the RMH opening
06 September 2021

The Melbourne Brain Centre at the Royal Melbourne Hospital (RMH) has just celebrated its 10th birthday.

06 September 2021

Researchers from Melbourne have led a global collaboration to develop a simplified blood test that increases the overall screening efficiency for type 1 diabetes.

02 September 2021

The Royal Melbourne Hospital’s (RMH) Scrub Choir is back and proud to introduce Scrub Sessions!

24 August 2021

There was nothing ordinary about the way Cheryl Poon showed her gratitude for the care she received after being hospitalised at the Royal Melbourne Hospital (RMH) with COVID-19 earlier this year.

20 August 2021

He wears scrubs instead of skivvies, but the Royal Melbourne Hospital’s (RMH) intensive care unit (ICU) nurse Steven Moylan wiggled into action to help a very special patient.

Do you have type 2 diabetes and your blood glucose levels could be better?

Diabetes (Type 2)

The purpose of this research study is to:

  • Test the safety and effectiveness of the study drug, INS068
  • Compare the study drug (INS068) to insulin degludec (Tresiba®)

Anticipated date that enrolment will close: end October 2021

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4

Seeking participants for Parkinson’s disease clinical trial

Parkinsons's disease

Cerevel Therapeutics has begun a study of an experimental drug called CVL-751 as a possible treatment for people with Parkinson’s disease. The main purpose of this study is to learn how safe the study is and how well it works. This is a randomised, double-blinded trial for people in the early stages of Parkinson's disease.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4

Seeking participants for Parkinson’s disease clinical trial

Parkinsons's disease

This is a study of an experimental treatment (referred to as “study drug”) called CVL-751 as a possible treatment for Parkinson’s disease. An experimental treatment is one that has not been approved by the United States (US) Food and Drug Administration (FDA), Therapeutic Goods Administration (TGA) in Australia or any other regulatory agency .

The main purpose of this study is to learn how well the study drug works and how safe the study drug is and to find the right dose. If you choose to participate in this study, you may receive the study drug, or you may receive placebo. A placebo is a medication with no active ingredients. It looks like the real thing but is not. Researchers use a placebo to see if the study drug works better or is safer than taking nothing.

Anticipated date that enrolment will close: 31 December 2021

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Subscribe to The Royal Melbourne Hospital RSS